Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients
- 14 February 2011
- journal article
- research article
- Published by Wiley in Oral Diseases
- Vol. 17 (2), 187-193
- https://doi.org/10.1111/j.1601-0825.2010.01717.x
Abstract
To investigate the level and interrelationship of nerve growth factor (NGF) and sensory neuropeptides [substance P (SP), calcitonin gene-related peptide (CGRP)] in plasma and saliva of chronic migraine patients, and to analyze the association between pain intensity and their concentration. Plasma and resting whole saliva were collected from 33 chronic migraine patients and 36 control subjects. NGF, SP, and CGRP concentrations were measured by enzyme immunoassay and pain intensity of each subject was measured using the Graded Chronic Pain Scale. Chronic migraine patients showed higher NGF and neuropeptide levels in both plasma and saliva compared to the control subjects. Plasma NGF, and plasma and saliva levels of SP and CGRP were highly associated with pain intensity. There was a significant positive correlation between NGF and both neuropeptide levels in plasma, and between the neuropeptide levels in both plasma and saliva. Plasma levels of SP and CGRP were significantly correlated with their saliva level. The increased production of NGF and sensory neuropeptides may play an important role in the maintenance of pain in chronic migraine and analysis results of human saliva could act as an index of disease state and therapeutic outcome.This publication has 36 references indexed in Scilit:
- Molecular Mechanisms of Sensitization of Pain-transducing P2X3 Receptors by the Migraine Mediators CGRP and NGFMolecular Neurobiology, 2008
- Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periodsPain, 2007
- Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytesNeuropeptides, 2006
- Oral fluid as a diagnostic toolcclm, 2004
- Chronic Daily Headache in A Tertiary Care Population: Correlation Between the International Headache Society Diagnostic Criteria and Proposed Revisions of Criteria for Chronic Daily HeadacheCephalalgia, 2002
- Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacksPain, 2000
- Epidemiology of Chronic Daily Headache in the General PopulationHeadache: The Journal of Head and Face Pain, 1999
- Nerve growth factor depletion by autoimmunization produces thermal hypoalgesia in adult ratsBrain Research, 1997
- Neuropepties in the saliva of healthy subjectsLife Sciences, 1996
- Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: Evidence for a regulatory function of nerve growth factor in vivoNeuroscience, 1992